Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$42.39
-3.08-6.77%
Last update: Oct 6, 4:12 PM
$42.39
-3.08-6.77%
Enliven Therapeutics Inc (ELVN) Stock Price, Quote, News & History
ELVNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Enliven Therapeutics (NASDAQ:ELVN) through any online brokerage.
Other companies in Enliven Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Enliven Therapeutics has a consensus price target of $65.92.
The stock price for Enliven Therapeutics (NASDAQ: ELVN) is $42.39 last updated October 6, 2026 at 4:12 PM EDT.
There are no upcoming dividends for Enliven Therapeutics.
Enliven Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Enliven Therapeutics.
Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
